nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2C8—Paclitaxel—ovarian cancer	0.122	0.249	CbGbCtD
Sulfadiazine—CYP3A4—Topotecan—ovarian cancer	0.0999	0.204	CbGbCtD
Sulfadiazine—CYP2C9—Paclitaxel—ovarian cancer	0.085	0.174	CbGbCtD
Sulfadiazine—CYP3A4—Vinorelbine—ovarian cancer	0.0704	0.144	CbGbCtD
Sulfadiazine—CYP3A4—Paclitaxel—ovarian cancer	0.0494	0.101	CbGbCtD
Sulfadiazine—CYP3A4—Docetaxel—ovarian cancer	0.0357	0.0731	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—ovarian cancer	0.0266	0.0545	CbGbCtD
Sulfadiazine—Skin exfoliation—Paclitaxel—ovarian cancer	0.00238	0.00465	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Topotecan—ovarian cancer	0.00237	0.00464	CcSEcCtD
Sulfadiazine—Stomatitis—Topotecan—ovarian cancer	0.00236	0.00462	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Melphalan—ovarian cancer	0.00232	0.00455	CcSEcCtD
Sulfadiazine—Eruption—Epirubicin—ovarian cancer	0.00231	0.00453	CcSEcCtD
Sulfadiazine—Stomatitis—Melphalan—ovarian cancer	0.00231	0.00452	CcSEcCtD
Sulfadiazine—Erythema multiforme—Chlorambucil—ovarian cancer	0.00231	0.00452	CcSEcCtD
Sulfadiazine—Oliguria—Docetaxel—ovarian cancer	0.00229	0.00448	CcSEcCtD
Sulfadiazine—Pancreatitis—Vinorelbine—ovarian cancer	0.00228	0.00446	CcSEcCtD
Sulfadiazine—Sepsis—Paclitaxel—ovarian cancer	0.00216	0.00423	CcSEcCtD
Sulfadiazine—Eruption—Doxorubicin—ovarian cancer	0.00214	0.00419	CcSEcCtD
Sulfadiazine—Hepatitis—Melphalan—ovarian cancer	0.00213	0.00416	CcSEcCtD
Sulfadiazine—Polyuria—Paclitaxel—ovarian cancer	0.00206	0.00403	CcSEcCtD
Sulfadiazine—Burning sensation—Epirubicin—ovarian cancer	0.00205	0.00401	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00203	0.00397	CcSEcCtD
Sulfadiazine—Stomatitis—Vinorelbine—ovarian cancer	0.00202	0.00395	CcSEcCtD
Sulfadiazine—Skin exfoliation—Docetaxel—ovarian cancer	0.00201	0.00394	CcSEcCtD
Sulfadiazine—Chills—Topotecan—ovarian cancer	0.00195	0.00382	CcSEcCtD
Sulfadiazine—Agranulocytosis—Vinorelbine—ovarian cancer	0.00193	0.00378	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00192	0.00375	CcSEcCtD
Sulfadiazine—Neuritis—Epirubicin—ovarian cancer	0.00191	0.00373	CcSEcCtD
Sulfadiazine—Leukopenia—Chlorambucil—ovarian cancer	0.0019	0.00372	CcSEcCtD
Sulfadiazine—Burning sensation—Doxorubicin—ovarian cancer	0.0019	0.00371	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00185	0.00362	CcSEcCtD
Sulfadiazine—Convulsion—Chlorambucil—ovarian cancer	0.00184	0.0036	CcSEcCtD
Sulfadiazine—Sepsis—Docetaxel—ovarian cancer	0.00183	0.00358	CcSEcCtD
Sulfadiazine—Neuritis—Doxorubicin—ovarian cancer	0.00176	0.00345	CcSEcCtD
Sulfadiazine—Blood disorder—Epirubicin—ovarian cancer	0.0017	0.00334	CcSEcCtD
Sulfadiazine—Ataxia—Paclitaxel—ovarian cancer	0.0017	0.00333	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.0017	0.00332	CcSEcCtD
Sulfadiazine—Leukopenia—Topotecan—ovarian cancer	0.00169	0.00331	CcSEcCtD
Sulfadiazine—Leukopenia—Melphalan—ovarian cancer	0.00166	0.00324	CcSEcCtD
Sulfadiazine—Anorexia—Chlorambucil—ovarian cancer	0.00165	0.00323	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00163	0.00318	CcSEcCtD
Sulfadiazine—Arthralgia—Topotecan—ovarian cancer	0.00161	0.00315	CcSEcCtD
Sulfadiazine—Convulsion—Melphalan—ovarian cancer	0.0016	0.00314	CcSEcCtD
Sulfadiazine—Blood disorder—Doxorubicin—ovarian cancer	0.00158	0.00309	CcSEcCtD
Sulfadiazine—Skin discolouration—Epirubicin—ovarian cancer	0.00158	0.00308	CcSEcCtD
Sulfadiazine—Oliguria—Epirubicin—ovarian cancer	0.00154	0.00302	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Topotecan—ovarian cancer	0.00154	0.00302	CcSEcCtD
Sulfadiazine—Pancreatitis—Paclitaxel—ovarian cancer	0.00153	0.003	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Melphalan—ovarian cancer	0.00151	0.00296	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Topotecan—ovarian cancer	0.00151	0.00296	CcSEcCtD
Sulfadiazine—Decreased appetite—Chlorambucil—ovarian cancer	0.00151	0.00295	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.0015	0.00293	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Melphalan—ovarian cancer	0.00148	0.0029	CcSEcCtD
Sulfadiazine—Anorexia—Topotecan—ovarian cancer	0.00147	0.00288	CcSEcCtD
Sulfadiazine—Skin discolouration—Doxorubicin—ovarian cancer	0.00146	0.00285	CcSEcCtD
Sulfadiazine—Vertigo—Vinorelbine—ovarian cancer	0.00145	0.00285	CcSEcCtD
Sulfadiazine—Leukopenia—Vinorelbine—ovarian cancer	0.00145	0.00283	CcSEcCtD
Sulfadiazine—Anorexia—Melphalan—ovarian cancer	0.00144	0.00282	CcSEcCtD
Sulfadiazine—Ataxia—Docetaxel—ovarian cancer	0.00144	0.00282	CcSEcCtD
Sulfadiazine—Oliguria—Doxorubicin—ovarian cancer	0.00143	0.0028	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00142	0.00278	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00141	0.00275	CcSEcCtD
Sulfadiazine—Depression—Paclitaxel—ovarian cancer	0.00139	0.00272	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00138	0.0027	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00138	0.0027	CcSEcCtD
Sulfadiazine—Urticaria—Chlorambucil—ovarian cancer	0.00138	0.0027	CcSEcCtD
Sulfadiazine—Arthralgia—Vinorelbine—ovarian cancer	0.00138	0.0027	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00138	0.0027	CcSEcCtD
Sulfadiazine—Abdominal pain—Chlorambucil—ovarian cancer	0.00137	0.00268	CcSEcCtD
Sulfadiazine—Body temperature increased—Chlorambucil—ovarian cancer	0.00137	0.00268	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00137	0.00267	CcSEcCtD
Sulfadiazine—Skin exfoliation—Epirubicin—ovarian cancer	0.00136	0.00266	CcSEcCtD
Sulfadiazine—Stomatitis—Paclitaxel—ovarian cancer	0.00136	0.00266	CcSEcCtD
Sulfadiazine—Decreased appetite—Topotecan—ovarian cancer	0.00134	0.00263	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Epirubicin—ovarian cancer	0.00134	0.00262	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00133	0.00261	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00132	0.00258	CcSEcCtD
Sulfadiazine—Decreased appetite—Melphalan—ovarian cancer	0.00131	0.00257	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.0013	0.00255	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00129	0.00253	CcSEcCtD
Sulfadiazine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00128	0.0025	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Topotecan—ovarian cancer	0.00126	0.00247	CcSEcCtD
Sulfadiazine—Anorexia—Vinorelbine—ovarian cancer	0.00126	0.00246	CcSEcCtD
Sulfadiazine—Skin exfoliation—Doxorubicin—ovarian cancer	0.00126	0.00246	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00124	0.00242	CcSEcCtD
Sulfadiazine—Sepsis—Epirubicin—ovarian cancer	0.00124	0.00242	CcSEcCtD
Sulfadiazine—Pruritus—Chlorambucil—ovarian cancer	0.00123	0.0024	CcSEcCtD
Sulfadiazine—Urticaria—Topotecan—ovarian cancer	0.00123	0.0024	CcSEcCtD
Sulfadiazine—Abdominal pain—Topotecan—ovarian cancer	0.00122	0.00239	CcSEcCtD
Sulfadiazine—Body temperature increased—Topotecan—ovarian cancer	0.00122	0.00239	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.0012	0.00235	CcSEcCtD
Sulfadiazine—Urticaria—Melphalan—ovarian cancer	0.0012	0.00235	CcSEcCtD
Sulfadiazine—Diarrhoea—Chlorambucil—ovarian cancer	0.00119	0.00232	CcSEcCtD
Sulfadiazine—Erythema multiforme—Paclitaxel—ovarian cancer	0.00118	0.00231	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00117	0.00229	CcSEcCtD
Sulfadiazine—Tinnitus—Paclitaxel—ovarian cancer	0.00117	0.00228	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00116	0.00226	CcSEcCtD
Sulfadiazine—Vascular purpura—Epirubicin—ovarian cancer	0.00115	0.00226	CcSEcCtD
Sulfadiazine—Stomatitis—Docetaxel—ovarian cancer	0.00115	0.00225	CcSEcCtD
Sulfadiazine—Decreased appetite—Vinorelbine—ovarian cancer	0.00115	0.00225	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—ovarian cancer	0.00114	0.00224	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00114	0.00223	CcSEcCtD
Sulfadiazine—Hypersensitivity—Topotecan—ovarian cancer	0.00114	0.00223	CcSEcCtD
Sulfadiazine—Chills—Paclitaxel—ovarian cancer	0.00112	0.0022	CcSEcCtD
Sulfadiazine—Hypersensitivity—Melphalan—ovarian cancer	0.00111	0.00218	CcSEcCtD
Sulfadiazine—Vomiting—Chlorambucil—ovarian cancer	0.0011	0.00216	CcSEcCtD
Sulfadiazine—Agranulocytosis—Docetaxel—ovarian cancer	0.0011	0.00216	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00109	0.00214	CcSEcCtD
Sulfadiazine—Pruritus—Topotecan—ovarian cancer	0.00109	0.00214	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00108	0.00211	CcSEcCtD
Sulfadiazine—Purpura—Epirubicin—ovarian cancer	0.00107	0.0021	CcSEcCtD
Sulfadiazine—Pruritus—Melphalan—ovarian cancer	0.00107	0.00209	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—ovarian cancer	0.00107	0.00209	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00107	0.00209	CcSEcCtD
Sulfadiazine—Hepatitis—Docetaxel—ovarian cancer	0.00106	0.00207	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Epirubicin—ovarian cancer	0.00106	0.00207	CcSEcCtD
Sulfadiazine—Diarrhoea—Topotecan—ovarian cancer	0.00106	0.00207	CcSEcCtD
Sulfadiazine—Urticaria—Vinorelbine—ovarian cancer	0.00105	0.00205	CcSEcCtD
Sulfadiazine—Abdominal pain—Vinorelbine—ovarian cancer	0.00104	0.00204	CcSEcCtD
Sulfadiazine—Body temperature increased—Vinorelbine—ovarian cancer	0.00104	0.00204	CcSEcCtD
Sulfadiazine—Diarrhoea—Melphalan—ovarian cancer	0.00103	0.00202	CcSEcCtD
Sulfadiazine—Nausea—Chlorambucil—ovarian cancer	0.00103	0.00202	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00101	0.00198	CcSEcCtD
Sulfadiazine—Erythema multiforme—Docetaxel—ovarian cancer	0.001	0.00196	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—ovarian cancer	0.000992	0.00194	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000988	0.00193	CcSEcCtD
Sulfadiazine—Vomiting—Topotecan—ovarian cancer	0.000981	0.00192	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00098	0.00192	CcSEcCtD
Sulfadiazine—Vertigo—Paclitaxel—ovarian cancer	0.000978	0.00191	CcSEcCtD
Sulfadiazine—Leukopenia—Paclitaxel—ovarian cancer	0.000974	0.00191	CcSEcCtD
Sulfadiazine—Rash—Topotecan—ovarian cancer	0.000973	0.0019	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000973	0.0019	CcSEcCtD
Sulfadiazine—Dermatitis—Topotecan—ovarian cancer	0.000972	0.0019	CcSEcCtD
Sulfadiazine—Ataxia—Epirubicin—ovarian cancer	0.000971	0.0019	CcSEcCtD
Sulfadiazine—Headache—Topotecan—ovarian cancer	0.000967	0.00189	CcSEcCtD
Sulfadiazine—Vomiting—Melphalan—ovarian cancer	0.000961	0.00188	CcSEcCtD
Sulfadiazine—Rash—Melphalan—ovarian cancer	0.000953	0.00187	CcSEcCtD
Sulfadiazine—Dermatitis—Melphalan—ovarian cancer	0.000952	0.00186	CcSEcCtD
Sulfadiazine—Chills—Docetaxel—ovarian cancer	0.000951	0.00186	CcSEcCtD
Sulfadiazine—Convulsion—Paclitaxel—ovarian cancer	0.000943	0.00185	CcSEcCtD
Sulfadiazine—Pruritus—Vinorelbine—ovarian cancer	0.000934	0.00183	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00093	0.00182	CcSEcCtD
Sulfadiazine—Arthralgia—Paclitaxel—ovarian cancer	0.000927	0.00181	CcSEcCtD
Sulfadiazine—Nausea—Topotecan—ovarian cancer	0.000917	0.00179	CcSEcCtD
Sulfadiazine—Diarrhoea—Vinorelbine—ovarian cancer	0.000903	0.00177	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—ovarian cancer	0.000899	0.00176	CcSEcCtD
Sulfadiazine—Nausea—Melphalan—ovarian cancer	0.000898	0.00176	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000888	0.00174	CcSEcCtD
Sulfadiazine—Pancreatitis—Epirubicin—ovarian cancer	0.000875	0.00171	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00087	0.0017	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000861	0.00168	CcSEcCtD
Sulfadiazine—Anorexia—Paclitaxel—ovarian cancer	0.000847	0.00166	CcSEcCtD
Sulfadiazine—Vomiting—Vinorelbine—ovarian cancer	0.00084	0.00164	CcSEcCtD
Sulfadiazine—Rash—Vinorelbine—ovarian cancer	0.000833	0.00163	CcSEcCtD
Sulfadiazine—Dermatitis—Vinorelbine—ovarian cancer	0.000832	0.00163	CcSEcCtD
Sulfadiazine—Headache—Vinorelbine—ovarian cancer	0.000827	0.00162	CcSEcCtD
Sulfadiazine—Leukopenia—Docetaxel—ovarian cancer	0.000826	0.00162	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—ovarian cancer	0.00081	0.00159	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000809	0.00158	CcSEcCtD
Sulfadiazine—Insomnia—Paclitaxel—ovarian cancer	0.000803	0.00157	CcSEcCtD
Sulfadiazine—Convulsion—Docetaxel—ovarian cancer	0.000799	0.00156	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000789	0.00154	CcSEcCtD
Sulfadiazine—Arthralgia—Docetaxel—ovarian cancer	0.000785	0.00154	CcSEcCtD
Sulfadiazine—Nausea—Vinorelbine—ovarian cancer	0.000784	0.00154	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00078	0.00153	CcSEcCtD
Sulfadiazine—Stomatitis—Epirubicin—ovarian cancer	0.000776	0.00152	CcSEcCtD
Sulfadiazine—Decreased appetite—Paclitaxel—ovarian cancer	0.000772	0.00151	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000767	0.0015	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000753	0.00147	CcSEcCtD
Sulfadiazine—Agranulocytosis—Epirubicin—ovarian cancer	0.000743	0.00145	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000737	0.00144	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00073	0.00143	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000726	0.00142	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000722	0.00141	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—ovarian cancer	0.000718	0.00141	CcSEcCtD
Sulfadiazine—Anorexia—Docetaxel—ovarian cancer	0.000718	0.0014	CcSEcCtD
Sulfadiazine—Hepatitis—Epirubicin—ovarian cancer	0.000715	0.0014	CcSEcCtD
Sulfadiazine—Urticaria—Paclitaxel—ovarian cancer	0.000706	0.00138	CcSEcCtD
Sulfadiazine—Abdominal pain—Paclitaxel—ovarian cancer	0.000702	0.00137	CcSEcCtD
Sulfadiazine—Body temperature increased—Paclitaxel—ovarian cancer	0.000702	0.00137	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000687	0.00135	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000686	0.00134	CcSEcCtD
Sulfadiazine—Insomnia—Docetaxel—ovarian cancer	0.000681	0.00133	CcSEcCtD
Sulfadiazine—Erythema multiforme—Epirubicin—ovarian cancer	0.000676	0.00132	CcSEcCtD
Sulfadiazine—Tinnitus—Epirubicin—ovarian cancer	0.000666	0.0013	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—ovarian cancer	0.000661	0.00129	CcSEcCtD
Sulfadiazine—Decreased appetite—Docetaxel—ovarian cancer	0.000654	0.00128	CcSEcCtD
Sulfadiazine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000654	0.00128	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00065	0.00127	CcSEcCtD
Sulfadiazine—Chills—Epirubicin—ovarian cancer	0.000641	0.00126	CcSEcCtD
Sulfadiazine—Pruritus—Paclitaxel—ovarian cancer	0.000628	0.00123	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000625	0.00122	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—ovarian cancer	0.000617	0.00121	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000616	0.0012	CcSEcCtD
Sulfadiazine—Diarrhoea—Paclitaxel—ovarian cancer	0.000608	0.00119	CcSEcCtD
Sulfadiazine—Abdominal pain—Docetaxel—ovarian cancer	0.000595	0.00116	CcSEcCtD
Sulfadiazine—Body temperature increased—Docetaxel—ovarian cancer	0.000595	0.00116	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—ovarian cancer	0.000593	0.00116	CcSEcCtD
Sulfadiazine—Vomiting—Paclitaxel—ovarian cancer	0.000565	0.00111	CcSEcCtD
Sulfadiazine—Rash—Paclitaxel—ovarian cancer	0.00056	0.0011	CcSEcCtD
Sulfadiazine—Dermatitis—Paclitaxel—ovarian cancer	0.000559	0.0011	CcSEcCtD
Sulfadiazine—Vertigo—Epirubicin—ovarian cancer	0.000559	0.00109	CcSEcCtD
Sulfadiazine—Leukopenia—Epirubicin—ovarian cancer	0.000557	0.00109	CcSEcCtD
Sulfadiazine—Headache—Paclitaxel—ovarian cancer	0.000556	0.00109	CcSEcCtD
Sulfadiazine—Hypersensitivity—Docetaxel—ovarian cancer	0.000555	0.00109	CcSEcCtD
Sulfadiazine—Convulsion—Epirubicin—ovarian cancer	0.000539	0.00106	CcSEcCtD
Sulfadiazine—Pruritus—Docetaxel—ovarian cancer	0.000533	0.00104	CcSEcCtD
Sulfadiazine—Arthralgia—Epirubicin—ovarian cancer	0.00053	0.00104	CcSEcCtD
Sulfadiazine—Nausea—Paclitaxel—ovarian cancer	0.000528	0.00103	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—ovarian cancer	0.000517	0.00101	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—ovarian cancer	0.000515	0.00101	CcSEcCtD
Sulfadiazine—Diarrhoea—Docetaxel—ovarian cancer	0.000515	0.00101	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000508	0.000994	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—ovarian cancer	0.000499	0.000976	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000497	0.000973	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—ovarian cancer	0.00049	0.000959	CcSEcCtD
Sulfadiazine—Anorexia—Epirubicin—ovarian cancer	0.000484	0.000947	CcSEcCtD
Sulfadiazine—Vomiting—Docetaxel—ovarian cancer	0.000479	0.000937	CcSEcCtD
Sulfadiazine—Rash—Docetaxel—ovarian cancer	0.000475	0.000929	CcSEcCtD
Sulfadiazine—Dermatitis—Docetaxel—ovarian cancer	0.000474	0.000928	CcSEcCtD
Sulfadiazine—Headache—Docetaxel—ovarian cancer	0.000472	0.000923	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00047	0.00092	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000463	0.000905	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00046	0.0009	CcSEcCtD
Sulfadiazine—Insomnia—Epirubicin—ovarian cancer	0.000459	0.000899	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—ovarian cancer	0.000448	0.000877	CcSEcCtD
Sulfadiazine—Nausea—Docetaxel—ovarian cancer	0.000447	0.000875	CcSEcCtD
Sulfadiazine—Decreased appetite—Epirubicin—ovarian cancer	0.000441	0.000864	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000438	0.000858	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000428	0.000838	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—ovarian cancer	0.000425	0.000832	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000415	0.000813	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—ovarian cancer	0.000408	0.000799	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000406	0.000794	CcSEcCtD
Sulfadiazine—Urticaria—Epirubicin—ovarian cancer	0.000403	0.00079	CcSEcCtD
Sulfadiazine—Body temperature increased—Epirubicin—ovarian cancer	0.000401	0.000786	CcSEcCtD
Sulfadiazine—Abdominal pain—Epirubicin—ovarian cancer	0.000401	0.000786	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000384	0.000752	CcSEcCtD
Sulfadiazine—Hypersensitivity—Epirubicin—ovarian cancer	0.000374	0.000732	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—ovarian cancer	0.000373	0.000731	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—ovarian cancer	0.000371	0.000727	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—ovarian cancer	0.000371	0.000727	CcSEcCtD
Sulfadiazine—Pruritus—Epirubicin—ovarian cancer	0.000359	0.000703	CcSEcCtD
Sulfadiazine—Diarrhoea—Epirubicin—ovarian cancer	0.000347	0.00068	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000346	0.000677	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—ovarian cancer	0.000332	0.000651	CcSEcCtD
Sulfadiazine—Vomiting—Epirubicin—ovarian cancer	0.000323	0.000632	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—ovarian cancer	0.000321	0.000629	CcSEcCtD
Sulfadiazine—Rash—Epirubicin—ovarian cancer	0.00032	0.000627	CcSEcCtD
Sulfadiazine—Dermatitis—Epirubicin—ovarian cancer	0.00032	0.000626	CcSEcCtD
Sulfadiazine—Headache—Epirubicin—ovarian cancer	0.000318	0.000623	CcSEcCtD
Sulfadiazine—Nausea—Epirubicin—ovarian cancer	0.000302	0.00059	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—ovarian cancer	0.000299	0.000585	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—ovarian cancer	0.000296	0.00058	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—ovarian cancer	0.000296	0.000579	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—ovarian cancer	0.000294	0.000576	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—ovarian cancer	0.000279	0.000546	CcSEcCtD
